Left Menu
Development News Edition

Takeda-led COVID-19 plasma product to begin trial this month

An experimental COVID-19 therapy using blood plasma, developed by Japan's Takeda Pharmaceutical Co and its partners, is scheduled to begin a late-stage clinical trial after initial delays. The study, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) in the United States, is seeking to recruit 500 participants from the United States, Britain, Argentina and Denmark, according to posting on a website run by the U.S. government's National Institutes of Health (NIH).

Reuters | Updated: 17-09-2020 14:41 IST | Created: 17-09-2020 14:41 IST
Takeda-led COVID-19 plasma product to begin trial this month

An experimental COVID-19 therapy using blood plasma, developed by Japan's Takeda Pharmaceutical Co and its partners, is scheduled to begin a late-stage clinical trial after initial delays.

The study, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) in the United States, is seeking to recruit 500 participants from the United States, Britain, Argentina and Denmark, according to posting on a website run by the U.S. government's National Institutes of Health (NIH). The NIAID is an institute of the NIH.

The study, due to begin this month, seeks to compare outcomes from the plasma product to those from the drug Remdesivir and a placebo. The Takeda-led group, known as the CoVIg-19 Plasma Alliance, had originally sought to begin trials in July. A Takeda representative said further questions about the study should be directed to the NIAID.

The institute did not immediately respond to a request for comment. The alliance, which includes Biotest AG, CSL Behring, and Octapharma Plasma, is working on a hyperimmune globulin therapy derived from convalescent plasma. It offers a standardized dose of antibodies and does not need to be limited to patients with matching blood types.

Clinical supplies of the treatment were produced at Takeda's facility in the U.S. state of Georgia and at CSL Behring's facility in Bern, Switzerland.


TRENDING

OPINION / BLOG / INTERVIEW

Post-COVID-19 Nigeria needs a robust Health Management Information System to handle high disease burden

Nigeria is among a few countries that conceptualised a health management information system HMIS in the early 90s but implementation has been a challenge till date. Besides COVID-19, the country has a huge burden of communicable and non-com...

Morocco COVID-19 response: A fragile health system and the deteriorating situation

Learning from its European neighbors, Morocco imposed drastic measures from the initial stages of the COVID-19 outbreak to try to contain its spread. The strategy worked for a few months but the cases have surged after mid-June. In this sit...

COVID-19: Argentina’s health system inefficiencies exaggerate flaws of health information system

You can recover from a drop in the GDP, but you cant recover from death, was the straightforward mindset of Argentinas President Alberto Fernndez and defined the countrys response to COVID-19. The South American nation imposed a strict...

Rwanda’s COVID-19 response commendable but health information system needs improvement

Rwanda is consistently working to improve its health information system from many years. However, it is primarily dependent on the collection and reporting of health data on a monthly basis. Besides, evaluation studies on Rwandas HIS publis...

Videos

Latest News

EU-bound trucks from UK could face two-day delays after Brexit, Britain says

British trucks could face delays of up to two days to enter Europe and queues of around 7,000 lorries after Britain leaves the bloc at the end of this year, disrupting imports and exports of crucial goods, the government has warned. Michael...

Guj govt opposes Hardik's plea for relief in bail condition

The Gujarat government has opposed Congress leader Hardik Patels application filed in a sessions court here seeking temporary suspension of his bail condition that restricts him from leaving the state. Patel, who is the working president of...

CBI books ex-VC of Visva Bharati University for alleged corruption

The CBI has registered an FIR against former Visva Bharati University vice-chancellor Sushanta Duttagupta for alleged corrupt activities during his tenure at the historic university, officials said on Wednesday. The action comes after a two...

EESL appoints Rajat Sud as Managing Director

State-run Energy Efficiency Services Ltd EESL on Wednesday announced the appointment of Rajat Sud as its Managing Director. Rajat Sud has taken over the charge of Managing Director of the EESL, a company statement said. Sud has taken over t...

Give Feedback